Dexamethasone: Data show implant improves vision in patients with RVO
November 1st 2009New data from phase III clinical trials of dexamethasone 0.7 mg intravitreal implant reaffirm that this novel pharmacotherapeutic intervention is well-tolerated and effectively improves vision in patients with macular edema secondary to a branch or central retinal vein occlusion.
Diabetic retinopathy: Association mapping holds key to understanding mechanism of major diseases
November 1st 2009Association mapping is a new perspective on the use of genomic tools that allows study of common disorders, such as diabetic retinopathy, and tries to tease apart genes as a way of studying disease pathophysiology.
CRUISE Phase III trial results: Ranibizumab safe, effective for macular edema
November 1st 2009Safety and efficacy analyses based on 6-month data collected in CRUISE phase III trial indicate a promising role of anti-vascular endothelial growth factor therapy with intravitreal ranibizumab in treatment of edema secondary to central retinal vein occlusion.
Pen-like tonometer designed to be patient-friendly
October 15th 2009A handheld tonometer that measures IOP through the eyelid and over the sclera is proving to be helpful for ophthalmologists faced with patients who are apprehensive about seeing an instrument approaching their eyesor who have a corneal abnormality.
Bascom Palmer takes top honors in annual survey
October 15th 2009Despite a challenging economy and diminished endowment funds, ophthalmology departments around the country continue to grow and thrive with new ideas, significant discoveries, and stronger faculties as they train the next generation of caregivers, researchers and educators.